Zomagen

Developer of small molecules harnessing the therapeutic potential of inflammasome modulation across autoimmune/inflammatory indications.

Read more

Morrow

Focused on the commercialization of spectacles with digital lens technology.

Read more

NorthSea Therapeutics

Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.

Read more

K2M

Acquired by Welsh, Carson, Anderson & Stowe. Developer of solutions for the treatment of complex spinal pathologies.

Read more

FlowCardia

Acquired by C.R. Bard. Developer of endovascular devices for the treatment of coronary and peripheral CTO.

Read more

Dezima

Acquired by Amgen. Focused on the development of a small molecule therapy for dyslipidemia.

Read more

Conor Medsystems

Acquired by Johnson & Johnson. Focused on the development of drug-eluting stents to treat coronary artery disease.

Read more